8YY.SI stock down 5.41% to S$0.07 on 04 Feb 2026 (Market closed): next signals

8YY.SI stock closed down 5.41% at S$0.07 on 04 Feb 2026 on the Singapore Exchange (SES). Trading volume reached 14,167,000 shares, slightly below the 30‑day average. The drop places Embracing Future Holdings Limited (8YY.SI) among today’s top losers as the healthcare small‑cap grapples with thin liquidity, elevated valuation ratios and mixed technical signals. We examine what moved the price, the company’s financial picture, Meyka AI’s grade and forecast, and realistic price targets for traders and longer‑term investors.

Price action and market context for 8YY.SI stock

Embracing Future Holdings Limited (8YY.SI) opened at S$0.075 and hit a session low of S$0.07 before close. The one‑day change of -S$0.004 equals -5.4054% on the SES. Market cap stands at S$121,340,927 with 1,733,441,815 shares outstanding. The 50‑day average is S$0.0525 and the 200‑day average is S$0.03006, indicating recent strength versus longer term. Year range is S$0.016–S$0.092, so today’s price sits closer to the upper half of the 12‑month band.

What likely drove the sell‑off in 8YY.SI stock

Trading volume of 14.17M was high relative to recent sessions but below the 30‑day average of 16.37M, suggesting measured selling. The healthcare sector showed muted performance this session, and Embracing Future’s thin free cash and negative margins increase sensitivity to short‑term flows. Key valuation flags include price‑to‑sales 68.48 and price‑to‑book 98.36, which make the stock vulnerable to re‑rating on any weak update. No EPS or PE data are reported, and the next earnings announcement is scheduled for 04 Mar 2026.

Technical setup and volume signals for 8YY.SI stock

Momentum indicators read mixed. RSI is 80.56 (overbought) and ADX is 68.82, showing a strong trend but high short‑term heat. Bollinger Bands sit at Upper 0.06 / Middle 0.04 / Lower 0.02, and the stock trades above the middle band. On balance volume (OBV) is elevated at 423,526,800, which shows accumulation over time but recent selling trimmed gains. Short‑term traders should note the high MFI of 83.34, which signals potential pullback risk.

Meyka AI rates 8YY.SI with a score out of 100 and analysis

Meyka AI rates 8YY.SI with a score out of 100: 56.67 (C+) — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score reflects thin fundamentals: negative net income per share (-0.00067), tight cash per share (0.00019), high debt‑to‑equity (2.26) and stretched valuation ratios. The grade is informational only and not investment advice.

Valuation, risks and sector context for 8YY.SI stock

Embracing Future sits in the Healthcare sector (Medical – Diagnostics & Research) on the SES, where peers show average PE near 22.08 and average PB near 1.71. By contrast, 8YY.SI’s PB is 98.36 and price/sales is 68.48, highlighting valuation risk. Operational risks include negative operating cash flow per share (-0.00171), current ratio 0.58, and concentrated operations across Japan, Hong Kong and the US. Upside hinges on commercial uptake of the ClearCell FX1 system and improved lab services revenue.

Analyst view, price targets and trading strategy for 8YY.SI stock

Analyst coverage is limited and external consensus data are not available. For prudent planning we present scenario targets: short‑term target S$0.08 (implied +14.29%), 12‑month base S$0.06 (implied -14.29%), bull S$0.12 (implied +71.43%) and bear S$0.04 (implied -42.86%). Traders should use strict risk limits due to low liquidity and high volatility. Watch the earnings release on 04 Mar 2026 and any SGX announcements for catalysts. Internal Meyka stock page has live charts and alerts for 8YY.SI.

Final Thoughts

Key takeaways: 8YY.SI stock closed at S$0.07 on 04 Feb 2026, down 5.41%, with 14.17M shares traded on the SES. Valuation metrics remain stretched — price/sales 68.48 and price/book 98.36 — while cash flow and profitability are negative. Meyka AI’s forecast model projects a monthly level of S$0.09 and a quarterly figure of S$0.04. The monthly projection implies +28.57% upside versus today’s price, while the quarterly projection implies -42.86% downside. Meyka AI’s forecast model projects these figures as model‑based estimates; forecasts are not guarantees. Given the C+ (56.67) grade and the company’s leverage and tight liquidity, we label the position a HOLD for cautious investors and a trade‑setup for nimble traders with defined stop losses. Monitor earnings on 04 Mar 2026 and SGX disclosures for fresh catalysts before increasing exposure.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.